VahatiCor, Inc., a medtech company developing interventional therapies for coronary microvascular dysfunction (CMD), today announced the enrollment of the first United States patient in its SERRA-I ...

LOS ANGELES (KABC) -- Doctors know how to spot large artery blockages when someone is experiencing heart attack symptoms, but often not those in the smaller heart ...

Coronary microvascular dysfunction (CMD) was an important independent component of ischemic heart disease, though it often accompanied epicardial coronary artery disease, a prospective study showed.

Garden-variety exercise stress testing can be used in patients who have angina with nonobstructive coronary arteries (ANOCA) to uncover the presence of coronary microvascular dysfunction (CMD), new ...

Please provide your email address to receive an email when new articles are posted on . Almost one-third of patients with psoriasis also had coronary microvascular dysfunction (CMD). Psoriasis ...

Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...

A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...

Exercise electrocardiographic (ECG) stress tests appeared to reliably indicate that some patients with angina with nonobstructive coronary arteries (ANOCA) actually had coronary microvascular ...

Patti Hutton of Liberty Township with Dr. Odayme Quesada, medical director of the Women's Heart Center at The Christ Hospital. Patti Hutton spent 15 years dealing with severe stabbing pain in her ...

Bridgeport, Conn. (WTNH) – On today’s “Yale New Haven Health Check,” Host Natasha Lubczenko spoke with David Louis, MD, Interventional Cardiology, of Bridgeport Hospital’s Heart & Vascular Center, ...